SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-004236
Filing Date
2024-02-16
Accepted
2024-02-16 18:37:03
Documents
1
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 form4-02162024_110255.html 4  
1 form4-02162024_110255.xml 4 8528
  Complete submission text file 0001415889-24-004236.txt   9978
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SENSEI BIOTHERAPEUTICS, INC. 451 D STREET, SUITE 710 BOSTON MA 02210
Business Address
van der Horst Edward (Reporting) CIK: 0001957499 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39980 | Film No.: 24650028